Rockland Immunochemicals

Rockland Immunochemicals is a global biotechnology company manufacturing leading edge research tools and cGMP grade proteins for basic, applied and clinical research in functional genomics, gene therapy and drug discovery markets. Rockland operates outside of Philadelphia, Pennsylvania, USA. European and Asian markets are supported through a highly specialized network of key distributors.

Technology:

The technology base of the organization is the experience of its staff scientists in the production and purification of a wide range of antibodies through monoclonal & polyclonal antibody techniques utilizing in vitro and in vivo methods. Our staff is also experienced in recombinant protein generation using bacterial, yeast and mammalian expression systems. Send us your gene(s) of interest and we will subclone into the appropriate expression vector, transform/transfect the appropriate system, express the protein in culture and purify the target protein to homogeneity.



Commercialization:

Rockland's antibodies are suited for individuals performing High Throughput Screening, Drug Discovery, diagnostic kit production and life science research. Primary antibodies include Apolipoproteins, Apoptosis/Cell Cycle, Cytokines, Cell Signaling, Enzymes, Extracellular Matrix, Transcription Factors (NFkB) and Ubiquitin. Secondary antibodies are conjugated to a broad range of enzymes, fluorphors and Magnetic Particles. ROCKLAND has the ability to custom produce antibodies as well as purify and conjugate them to your exact specifications.

Contact Details: P.O. Box 326 Gilbertsville PA 19525 United States of America Tel: 800-656-ROCK Fax: Email: orders@rockland-inc.com WWW: www.rockland-inc.com/

Loading...

Press Releases on Rockland Immunochemicals:
BioInformatics, LLC New Report - Exploring the Epigenetics Market: Opportunities for Product Placement and Innovations	18th June, 2009	BioInformatics, LLC	ARLINGTON, Va., June 18 /PRNewswire/ -- BioInformatics, LLC announces the pending release of its newest report, Exploring the Epigenetics Market: Opportunities for Product Placement and Innovations.

BioNews Results for Rockland Immunochemicals:
Swifter flu vaccine process sought	Wicked Local Dennis:  Nov 1 2009 1:44PM Matching: rockland
Rockland woman's garden helped her get through cancer treatments	Rockland Standard:  Oct 30 2009 5:47PM Matching: rockland
BioSphere Medical Reports Third Quarter Revenue of $7.69 Million and a Narrowed Net Loss of $0.02 Per Share	SmartBrief:  Oct 29 2009 7:06AM Matching: rockland
BioSphere Medical Reports Third Quarter Revenue of $7.69 Million and a Narrowed Net Loss of $0.02 Per Share	NewsBlaze:  Oct 29 2009 3:36AM Matching: rockland
Lets Talk About Breast Cancer	Discover Magazine:  Oct 27 2009 12:10AM Matching: rockland
Promote your company here: BioNewsCast - Press Release Distribution	→View more Rockland Immunochemicals news.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 340 times since April 2007, the link to the organisation's website has been followed 58 times

Recent Search Terms used to find this page: rockland immunochemicals press release | rockland immunochemicals | rockland immunochemicals sellers | rockland immuno | uses of immunochemicals | Rockland Immunochemicals and antibodies | rockland immunochemicals | Rockland Immunochemicals Press Release | rockland antibodies | .

Search for more companies in Gilbertsville

Search for more companies in PA

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Rockland Immunochemicals